Screener
DBV Technologies DBVT VIASKIN® Peanut — Sales & Marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DBV Technologies in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.
- Filed
- Jul 16, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-048453
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Clinical studies | 9.9 | 16.3 | 21.3 | 23.1 |
| BLA & Regulatory | 5.6 | 2.3 | 11.9 | 3.7 |
| Medical Affairs & Other Medical | 5.1 | 2.0 | 10.0 | 4.0 |
| Research & Innovation | 0.8 | 0.3 | 1.1 | 1.1 |
| Manufacturing & Supply and Quality | 9.9 | 12.8 | 20.4 | 23.4 |
| Sales & Marketing | 5.5 | 0.4 | 10.4 | 0.7 |
| General & Administrative | 14.6 | 8.5 | 25.1 | 14.1 |
| Total expenses | 51.3 | 42.6 | 100.1 | 70.0 |
Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of
FAQ
- What is DBV Technologies's VIASKIN® peanut — sales & marketing?
- DBV Technologies (DBVT) reported VIASKIN® peanut — sales & marketing of $5.5M in Q2 2026.
- How has DBV Technologies's VIASKIN® peanut — sales & marketing changed year-over-year?
- DBV Technologies's VIASKIN® peanut — sales & marketing increased by 1275.0% year-over-year, from $400K to $5.5M.
- What is the long-term trend for DBV Technologies's VIASKIN® peanut — sales & marketing?
- Over 2 years (2023 to 2025), DBV Technologies's VIASKIN® peanut — sales & marketing has grown at a 15.3% compound annual growth rate (CAGR), from $2.44M to $3.24M.
- What does VIASKIN® peanut — sales & marketing mean?
- Captures the expenditures dedicated to the commercial preparation, market education, and promotional activities for the Viaskin Peanut product line. These costs reflect the company's efforts to build brand awareness and prepare for potential market entry. It is a key indicator of commercial readiness and the scale of pre-launch market development.
Ask your AI about DBV Technologies's viaskin® peanut — sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude